| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Jagadishwar Pharmaceuticals Works Limited |
|
Particulars |
31-03-2022 |
31-03-2021 |
|
Assets |
|
|
|
Non-Current Assets |
|
|
|
Investments |
12,95,94,147.54 |
130230881.07 |
|
Other Non-Current Assets |
415021.00 |
247369.00 |
|
Current Assets |
|
|
|
Inventories |
4,30,28,802.04 |
4,29,09,773.80 |
|
Cash and Cash Equivalents |
64,70,981.65 |
8,30,259.57 |
|
Loans |
4,76,97,794.00 |
7,17,82,439.00 |
|
Other Current Assets |
8,13,72,287.40 |
6,22,77,287.40 |
|
Total Assets |
30,85,79,033.63 |
308278009.84 |
|
Equity & Liabilities |
|
|
|
Equity |
|
|
|
Share Capital |
29,70,01,900.00 |
297001900.00 |
|
Other Equity |
1,15,67,373.63 |
1,12,66,349.84 |
|
Liabilities |
|
|
|
Current Liabilities |
|
|
|
Other Liabilities |
9,760.00 |
9,760.00 |
|
Total Equity and Liabilities |
30,85,79,033.63 |
308278009.84 |
|
Particulars |
31-03-2022 |
31-03-2021 |
|
Revenue from operations |
1,84,500.00 |
3,50,80,085.00 |
|
Other income |
50,61,221.00 |
56,59,916.00 |
|
Total Income |
52,45,721.00 |
4,07,40,001.00 |
|
Purchase |
3,03,528.00 |
5,38,720.00 |
|
Changes in inventory of Finished Goods |
-1,19,028.24 |
3,64,11,570.00 |
|
Employee benefit expenses |
20,19,188.00 |
15,19,490.00 |
|
Other expenses |
17,65,805.92 |
10,32,903.00 |
|
Total expenses |
39,69,493.68 |
3,95,02,683.00 |
|
Profit before tax |
12,76,227.32 |
12,37,318.00 |
|
Tax Expense for Current Year |
3,38,470.00 |
3,35,360.00 |
|
Profit/(loss) for the year |
9,37,757.32 |
9,01,958.00 |
|
Items that will not be reclassified to profit or loss-Actuarial (Loss)/Gain |
-6,36,733.53 |
4,35,090.02 |
|
Other Comprehensive Income |
-6,36,733.53 |
4,35,090.02 |
|
Total Comprehensive Income for the Year |
3,01,023.79 |
13,37,048.02 |
|
Earnings per Equity Share |
|
|
|
Basic and Diluted |
0.38 |
0.03 |
|
Particulars |
31-03-2022 |
31-03-2021 |
|
Cash flows from operating activities |
|
|
|
Net Profit/(loss) before Taxation |
12,76,227.32 |
12,37,318.00 |
|
Adjustments for: |
- |
- |
|
Interest income |
-50,61,221.00 |
-56,59,916.00 |
|
Operating profit before working capital changes |
-37,84,993.68 |
-44,22,598.00 |
|
Adjustment for : |
|
|
|
Change in Inventories |
-119028.24 |
36411570 |
|
Change in Other Current Liabilities |
- |
-2,740.00 |
|
Change in Financial Loans |
24084645 |
-4,52,76,440.00 |
|
Change in Other Current Assets |
-1,90,95,000.00 |
-3,39,50,000.00 |
|
Changes in working capital |
48,70,616.76 |
-42817610.00 |
|
Cash Generated from Operations |
10,85,623.08 |
-47240208.00 |
|
Income Tax Paid |
-5,06,122.00 |
-356859.00 |
|
Net cash from operating activities |
5,79,501.08 |
-47597067.00 |
|
Cash flows from investing activities |
- |
- |
|
- Adjustment for :- |
|
|
|
Non Current Financial Assets |
- |
42204520.5 |
|
Interest Income |
5061221 |
5659916 |
|
Net cash generated by investing activities |
5061221.00 |
47864436.50 |
|
Net increase/(decrease) in cash and cash equivalents |
56,40,722.08 |
267369.50 |
|
Cash and cash equivalents at the beginning of the year |
830259.57 |
562890.07 |
|
Cash and cash equivalents at the end of the year |
64,70,981.65 |
830259.57 |
Here is a summary of the Cash Flow Statement for the years 2022 and 2021:
Operating Activities:
Net Profit Before Taxation: The net profit before taxation increased from 12,37,318.00 in 2021 to 12,76,227.32 in 2022, indicating improved profitability.
Interest Income: There was a significant decrease in interest income from -56,59,916.00 in 2021 to -50,61,221.00 in 2022.
Operating Profit Before Working Capital Changes: There was a decrease in operating profit before working capital changes from -44,22,598.00 in 2021 to -37,84,993.68 in 2022.
Changes in Working Capital: There was a positive change in working capital, with cash generated from operations increasing from -4,72,40,208.00 in 2021 to 10,85,623.08 in 2022.
Income Tax Paid: Income tax paid increased from -3,56,859.00 in 2021 to -5,06,122.00 in 2022.
Investing Activities:
There is no information provided for investing activities in both years.
Cash and Cash Equivalents:
Net Increase/(Decrease) in Cash: The net increase in cash and cash equivalents was significant, rising from 2,67,369.50 in 2021 to 56,40,722.08 in 2022.
Cash and Cash Equivalents at the Beginning and End of the Year: The cash and cash equivalents at the beginning of the year were 5,62,890.07 in 2021 and increased to 8,30,259.57 in 2022. By the end of the year, cash and cash equivalents rose to 64,70,981.65 in 2022 from 8,30,259.57 in 2021.
In summary, in 2022, the company experienced improved profitability with an increase in net profit before taxation. Despite a decrease in interest income and operating profit before working capital changes, there was a positive change in working capital, resulting in cash generated from operations. This led to a significant increase in cash and cash equivalents compared to the previous year. Additionally, there were no significant investing activities reported for both years.
|
PARTICULARS |
2022 |
2021 |
|
Dividend Per Share |
- |
- |
|
Retained Earnings (In Rs.) |
47,42,454.09 |
38,04,696.77 |
